GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 49 weeks, 7kg, and dose escalation was the hard part — 47 comments in the full submission. View in context.
1.4k
c/retatrutide·submitted 4 months ago by u/divya_bakken

[Results] 49 weeks, 7kg, and dose escalation was the hard part

Resultsbranch of 7 comments

49 weeks, 7kg, and dose escalation was the hard part. Numbers below. Ask me the boring questions, they are the useful ones. Numbers, in the order they matter: 49 weeks and 7kg. Where the evidence actually stands, since every thread here assumes a different answer. Phase 2 reported a large mean body weight change at…

Read the full submission and all 47 comments →

This branch

7 comments, started 4 months ago
u/rui_only_ro42 points·4 months ago

Yes — the comparison threads are apples to oranges and they generate more heat than anything else here.

replysharereportpermalink
u/isabela_nilsen32 points·4 months ago

Watched heart rate on a wearable across twelve weeks because the threads said to. It moved a little and I have no idea whether that means anything.

replysharereportpermalink
u/divya_bakkenOP30 points·4 months ago

dose escalation in the trials was slow for a reason

replysharereportpermalink
u/solene_ilunga16 points·4 months ago

Same read. The energy-expenditure mechanism is the interesting bit and it is not established in humans at scale.

replysharereportpermalink
u/careful_gradient3218 points·4 months ago·edited

dose escalation in the trials was slow for a reason

This is the sentence the rest of the board should read first. Phase 2 is not a label.

replysharereportpermalink
u/clara_weiss14 points·4 months ago

nothing here is available as a prescription product, so read every thread with that in mind

replysharereportpermalink
u/yara_lindholm16 points·4 months ago

Disagree. "More receptors means more effect" is not how any of this works and the trial data does not support the linear story.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.